10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
BRISTOL MYERS SQUIBB CO | |||
Ticker: BMY Fiscal Year: 2010 | |||
CONSOLIDATED STATEMENTS OF EARNINGS | |||
Period Ending Dec 31, 2010 10-K (Filed: Feb 18, 2011) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | |
| EARNINGS | |||
| Net Sales | $ 19,484 | 18,808 | 17,715 |
| Cost of products sold | 5,277 | 5,140 | 5,316 |
| Marketing, selling and administrative | 3,686 | 3,946 | 4,140 |
| Research and development | 3,566 | 3,647 | 3,512 |
| Advertising and product promotion | 977 | 1,136 | 1,181 |
| Acquired in-process research and development | 32 | ||
| Provision for restructuring, net | 113 | 136 | 215 |
| Litigation expense, net | (19) | 132 | 33 |
| Equity in net income of affiliates | (313) | (550) | (617) |
| Gain on sale of ImClone shares | (895) | ||
| Other (income)/expense | 126 | (381) | 22 |
| Total Expenses | 13,413 | 13,206 | 12,939 |
| Earnings from Continuing Operations Before Income Taxes | 6,071 | 5,602 | 4,776 |
| Provision for income taxes | 1,558 | 1,182 | 1,090 |
| Net Earnings from Continuing Operations | 4,513 | 4,420 | 3,686 |
| Discontinued Operations: | |||
| Earnings, net of taxes | 285 | 578 | |
| Gain on disposal, net of taxes | 7,157 | 1,979 | |
| Net Earnings from Discontinued Operations | 7,442 | 2,557 | |
| Net Earnings | 4,513 | 11,862 | 6,243 |
| Net Earnings Attributable to Noncontrolling Interest | 1,411 | 1,250 | 996 |
| Net Earnings Attributable to Bristol-Myers Squibb Company | 3,102 | 10,612 | 5,247 |
| Amounts Attributable to Bristol-Myers Squibb Company: | |||
| Net Earnings from Continuing Operations | 3,102 | 3,239 | 2,697 |
| Net Earnings from Discontinued Operations | 7,373 | 2,550 | |
| Net Earnings Attributable to Bristol-Myers Squibb Company | 3,102 | 10,612 | 5,247 |
| Earnings per Common Share from Continuing Operations Attributable to Bristol-Myers Squibb Company: | |||
| Basic | 1.80 | 1.63 | 1.36 |
| Diluted | 1.79 | 1.63 | 1.35 |
| Earnings per Common Share Attributable to Bristol-Myers Squibb Company: | |||
| Basic | 1.80 | 5.35 | 2.64 |
| Diluted | 1.79 | 5.34 | 2.62 |
| Dividends declared per common share | 1.29 | 1.25 | 1.24 |
| External Links | |
| BRISTOL MYERS SQUIBB CO (BMY) Fiscal Year 2010 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |